393 related articles for article (PubMed ID: 30324535)
1. Clinical immunity in bone and joints.
Tanaka Y
J Bone Miner Metab; 2019 Jan; 37(1):2-8. PubMed ID: 30324535
[TBL] [Abstract][Full Text] [Related]
2. [Mechanism of bone destruction and the contribution of T lymphocytes].
Komatsu N
Nihon Rinsho; 2016 Jun; 74(6):907-12. PubMed ID: 27311177
[TBL] [Abstract][Full Text] [Related]
3. Periodontal Disease as a Risk Factor for Rheumatoid Arthritis: A Systematic Review.
Kaur S; White S; Bartold M
JBI Libr Syst Rev; 2012; 10(42 Suppl):1-12. PubMed ID: 27820156
[TBL] [Abstract][Full Text] [Related]
4. [Inflammatory cytokines for osteoclastogenesis].
Tanaka Y
Nihon Rinsho; 2005 Sep; 63(9):1535-40. PubMed ID: 16164208
[TBL] [Abstract][Full Text] [Related]
5. [Rheumatoid arthritis and cytokines].
Kaneko S; Kondo Y; Yokosawa M; Sumida T
Nihon Rinsho; 2016 Jun; 74(6):913-8. PubMed ID: 27311178
[TBL] [Abstract][Full Text] [Related]
6. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of joint destruction in rheumatoid arthritis - immune cell-fibroblast-bone interactions.
Komatsu N; Takayanagi H
Nat Rev Rheumatol; 2022 Jul; 18(7):415-429. PubMed ID: 35705856
[TBL] [Abstract][Full Text] [Related]
8. [Bone structure in rheumatoid arthritis].
Ono K; Ohashi S; Tanaka S; Matsumoto T
Clin Calcium; 2013 Jul; 23(7):983-91. PubMed ID: 23811586
[TBL] [Abstract][Full Text] [Related]
9. Osteoimmunology: The Crosstalk between T Cells, B Cells, and Osteoclasts in Rheumatoid Arthritis.
Yang M; Zhu L
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473934
[TBL] [Abstract][Full Text] [Related]
10. [Diagnosis and treatment of rheumatoid arthritis:toward the best practice. Anti-bone resorbing treatment for rheumatoid arthritis.].
Tanaka Y
Clin Calcium; 2018; 28(5):630-636. PubMed ID: 29731457
[TBL] [Abstract][Full Text] [Related]
11. [The impact of controlling bone remodeling in rheumatoid arthritis.].
Ebina K
Clin Calcium; 2017; 27(12):1739-1744. PubMed ID: 29179168
[TBL] [Abstract][Full Text] [Related]
12. Autoimmune arthritis: the interface between the immune system and joints.
Komatsu N; Takayanagi H
Adv Immunol; 2012; 115():45-71. PubMed ID: 22608255
[TBL] [Abstract][Full Text] [Related]
13. IL-6 signal blockade ameliorates the enhanced osteoclastogenesis and the associated joint destruction in a novel FcγRIIB-deficient rheumatoid arthritis mouse model.
Ohtsuji M; Lin Q; Nishikawa K; Ohtsuji N; Okazaki H; Tsurui H; Amano H; Shirai T; Nishimoto N; Nishimura H; Hirose S
Mod Rheumatol; 2015 Mar; 25(2):270-7. PubMed ID: 25159156
[TBL] [Abstract][Full Text] [Related]
14. Adipose-Derived Mesenchymal Stem Cells Prevent Systemic Bone Loss in Collagen-Induced Arthritis.
Garimella MG; Kour S; Piprode V; Mittal M; Kumar A; Rani L; Pote ST; Mishra GC; Chattopadhyay N; Wani MR
J Immunol; 2015 Dec; 195(11):5136-48. PubMed ID: 26538398
[TBL] [Abstract][Full Text] [Related]
15. Biologic therapies and systemic bone loss in rheumatoid arthritis.
Dimitroulas T; Nikas SN; Trontzas P; Kitas GD
Autoimmun Rev; 2013 Aug; 12(10):958-66. PubMed ID: 23542506
[TBL] [Abstract][Full Text] [Related]
16. Osteoblasts and osteoclasts in bone remodeling and inflammation.
Tanaka Y; Nakayamada S; Okada Y
Curr Drug Targets Inflamm Allergy; 2005 Jun; 4(3):325-8. PubMed ID: 16101541
[TBL] [Abstract][Full Text] [Related]
17. [Secondary osteoporosis or secondary contributors to bone loss in fracture. The relevance of immune system to bone metabolism].
Tanaka Y
Clin Calcium; 2013 Sep; 23(9):1265-70. PubMed ID: 23999361
[TBL] [Abstract][Full Text] [Related]
18. Immune-bone interplay in the structural damage in rheumatoid arthritis.
Komatsu N; Takayanagi H
Clin Exp Immunol; 2018 Oct; 194(1):1-8. PubMed ID: 30022480
[TBL] [Abstract][Full Text] [Related]
19. [Secondary osteoporosis. Bone metabolic disorder in Rheumatoid arthritis.].
Nakano K; Okada Y; Tanaka Y
Clin Calcium; 2018; 28(12):1599-1603. PubMed ID: 30487323
[TBL] [Abstract][Full Text] [Related]
20. Single and combined inhibition of tumor necrosis factor, interleukin-1, and RANKL pathways in tumor necrosis factor-induced arthritis: effects on synovial inflammation, bone erosion, and cartilage destruction.
Zwerina J; Hayer S; Tohidast-Akrad M; Bergmeister H; Redlich K; Feige U; Dunstan C; Kollias G; Steiner G; Smolen J; Schett G
Arthritis Rheum; 2004 Jan; 50(1):277-90. PubMed ID: 14730626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
